InspireMD Q4 revenue down 20.6% YoY; net loss widens to $4.8M; resumes CGuard shipments under MDD

InspireMD, Inc.

Q4 CGuard revenue $1.026M (-20.6% YoY) due to temporary CE Mark expiration; full year revenue $5.123M (+18.9%).
Net loss Q4 $4.845M ($0.60/share) vs $4.097M ($0.53) in Q4 2021; full year net loss $18.491M ($2.35/share).
Cash and equivalents $17.8M at Dec 31, 2022, down from $34.0M a year ago.
Resumed CGuard shipments to CE Mark territories in mid-March 2023 under MDD; expects MDR recertification in coming weeks.
US IDE trial enrollment on track to complete by end of Q2 2023; 20 sites currently enrolling.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

InspireMD, Inc. reported fourth quarter ended December 31, 2022 results: revenue $1,026,000, net income Net loss for the fourth quarter of 2022 totaled $4,845,000, or $0.60 per basic and diluted share, EPS $0.60 per basic and diluted share.

Period: fourth quarter ended December 31, 2022
Revenue: $1,026,000
Net income: Net loss for the fourth quarter of 2022 totaled $4,845,000, or $0.60 per basic and diluted share
EPS: $0.60 per basic and diluted share
Result: reported results

Exact text from the filing

and operating results for the fourth quarter ended December 31, 2022. Fourth Quarter 2022 and Recent Developments : ● Generated CGuard revenues for the fourth quarter 2022 of $1,026,000, a 20.6% decrease from $1,291,000 for the fourth quarter of 2021. The decrease was caused by reduced shipments due to the temporary expiration of the Company’s CE Mark for the

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

InspireMD, Inc. reported the year ended December 31, 2022 results: revenue $5,171,000.

Period: the year ended December 31, 2022
Revenue: $5,171,000
Result: reported results

Exact text from the filing

For the twelve months ended December 31, 2022, total revenue increased by $676,000, or 15.0%, to $5,171,000, from $4,495,000 during the twelve months ended December 31, 2021.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

InspireMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-009596

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.